New drug duo aims to knock out blood cancer
NCT ID NCT05718869
Summary
This study is testing whether combining two cancer drugs, tafasitamab and zanubrutinib, is safe and effective for people newly diagnosed with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if using both drugs together can kill more cancer cells and lead to better outcomes than using either drug alone. The trial will measure how well the treatment works and monitor for side effects in a small group of participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
-
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 33146, United States
Conditions
Explore the condition pages connected to this study.